Tranilast directly targets NLRP 3 to treat inflammasome‐driven diseases
نویسندگان
چکیده
منابع مشابه
Uricosuric targets of tranilast
Uric acid, generated from the metabolism of purines, has both proven and emerging roles in human disease. Serum uric acid in humans is determined by production and by the net balance of reabsorption and secretion in kidney and intestine. In the human kidney, epithelial reabsorption dominates over secretion, such that in normal subjects there is at least 90% net reabsorption of filtered urate re...
متن کاملNLRP 3 inflammasome activation by crystal structures
Crystal structures such as monosodium urate (MSU) crystals or cholesterol crystals can trigger an inflammatory response responsible for chronic diseases. These crystals are internalized by immune cells and activate the NLRP3 inflammasome, a multiprotein signaling complex of the innate immune system. That leads to the activation and secretion of the pro-inflammatory cytokines IL-1β and IL18, whi...
متن کاملTelomeres and telomerase as therapeutic targets to prevent and treat age-related diseases
Telomeres, the protective ends of linear chromosomes, shorten throughout an individual's lifetime. Telomere shortening is a hallmark of molecular aging and is associated with premature appearance of diseases associated with aging. Here, we discuss the role of telomere shortening as a direct cause for aging and age-related diseases. In particular, we draw attention to the fact that telomere leng...
متن کاملDoxycycline directly targets PAR1 to suppress tumor progression
Doxycycline have been reported to exert anti-cancer activity and have been assessed as anti-cancer agents in clinical trials. However, the direct targets of doxycycline in cancer cells remain unclear. In this study, we used a chemical proteomics approach to identify the Protease-activated receptor 1 (PAR1) as a specific target of inhibition of doxycycline. Binding assays and single-molecule ima...
متن کاملResveratrol directly targets COX-2 to inhibit carcinogenesis.
Targeted molecular cancer therapies can potentially deliver treatment directly to a specific protein or gene to optimize efficacy and reduce adverse side effects often associated with traditional chemotherapy. Key oncoprotein and oncogene targets are rapidly being identified based on their expression, pathogenesis and clinical outcome. One such protein target is cyclooxygenase-2 (COX-2), which ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: EMBO Molecular Medicine
سال: 2018
ISSN: 1757-4676,1757-4684
DOI: 10.15252/emmm.201708689